Corbus Pharmaceuticals Holdings, Inc. Conversion of Stock, Amount Issued
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Conversion of Stock, Amount Issued of $1.13 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2026-03-09
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for the quarter ending 2024-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for the quarter ending 2024-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for the quarter ending 2024-03-31 was $1.13M.
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for fiscal 2024 was $1.13M, a 28.57% increase from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. conversion of stock, amount issued for fiscal 2023 was $875.00K.
| Period end | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $1.13M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $1.13M 10-Q · filed 2025-11-12 | $1.13M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.13M 10-Q · filed 2025-08-05 | $1.13M derived: sum of 3 quarters · filed 2025-08-05 | $1.13M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $1.13M 10-Q · filed 2025-05-06 | $1.13M derived: sum of 2 quarters · filed 2025-05-06 | $1.13M derived: sum of 3 quarters · filed 2025-05-06 | $2.00M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $875.00K derived: sum of 3 quarters · filed 2025-03-11 | $875.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $875.00K derived: sum of 2 quarters · filed 2024-11-07 | $875.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $875.00K 10-Q · filed 2024-08-06 | $875.00K 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |